Employees of pharmacies have a negative attitude to the idea of introducing fines for insufficient information to buyers. Pharmacists believe that the information on... Pervostolnik want more information about drugs

Employees of pharmacies have a negative attitude to the idea of introducing fines for insufficient information to buyers. Pharmacists believe that the information on drugs they are not sufficient to efficiently perform the work. More than 90% of pharmacists want to receive more information about drugs that that sell. Such results were obtained in a survey of pharmacists research portal Pharmedu.

In the survey participated 1221 Respondent. Surveyed pharmacists shared his opinion about new laws, Ministry of health, and evaluated the amount and quality of information about new drugs.

23.1% of pharmacists believe the most important aspect of his work is the opportunity to learn in the workplace. Also important factors are understanding the leadership and the prospect of higher wages – is 21.7 and 22.2%, respectively. The survey also revealed that 58.7 per cent of pharmacists are satisfied with the schedule of their work.

The main sources of information about new drugs lead: online learning – 27.1%, with the pharmaceutical community, groups and forums – 23,9%, followed by advertising at 17.8%.

The results of the survey revealed the negative attitude of employees of the pharmaceutical industry to the bill of the Ministry of health about the penalties for insufficient information to buyers – 60,9% strongly against such initiatives. The attitude of pharmacists due to the lack of information on medicines and unclear evaluation criteria of the work performed.

Pharmacists believe that the information is sufficient to carry out every detail of their work, forcing them to seek additional sources. 74.6% of employees expressed a desire to obtain the necessary information about new drugs faster. Moreover, 90.6% of the surveyed pharmacists want to receive any additional information about medications that sell.

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *